Navigation Links
Dehaier Awarded $1.32 Million Procurement Contract to Supply Medical Devices to Hospital 301 in Beijing
Date:6/1/2011

BEIJING, June 1, 2011 /PRNewswire-Asia-FirstCall/ -- Dehaier Medical Systems Ltd. (NASDAQ: DHRM) ("Dehaier" or the "Company"), an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced that it has signed a medical equipment supply agreement with Hospital 301, which is located in Beijing, China. The contract is valued at $1.32 million, and Dehaier expects to recognize all revenues from the contract in 2011.

(Logo: http://photos.prnewswire.com/prnh/20100422/CNTH001LOGO)

Dehaier cooperated with German-based Leica Microsystems ("Leica") and U.S.-based ABI Medical ("ABI") to win the bid to distribute medical devices under the Hospital 301 procurement contract. Under the agreement Dehaier will provide the Hospital 301 with a Small Animal In-vivo Imaging System and two sets Laser Capture Microdissection Systems (LCM), both of which are manufactured by Leica, and DNA sequencers manufactured by ABI.

"Hospital 301 is one of the largest and most well renowned hospitals in China and we are honored to provide devices to the hospital. We are also pleased to have the chance to work with two well-respected medical device manufacturers such as Leica and ABI. This supply agreement demonstrates our ability to continue to make inroads with leading hospitals throughout the country and key international medical device manufacturers," said Mr. Ping Chen, CEO of Dehaier. "In over ten years of distributing medical devices in China, we have built strong relationships with over 3,000 hospitals and 2,000 dealers and distributors nationwide. Along with the solid development of medical devices business, we believe that this large, diversified growing network provides us with an ideal platform on which to expand and accelerate the growth of our homecare business."

About Dehaier Medical Systems Ltd.Dehaier is an emerging leader in the development, assembly, marketing and sale of medical products in China, including respiratory and oxygen homecare medical products. The company develops and assembles its own branded medical devices and homecare medical products from third-party components. The company also distributes products designed and manufactured by other companies, including medical devices from IMD (Italy), Welch Allyn (USA), HEYER (Germany), Timesco (UK), eVent Medical (US) and JMS (Japan). Dehaier's technology is based on two patents, six pending patents, and proprietary technology. More information may be found at http://www.chinadhr.com.

Forward-looking StatementsThis news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, future developments in payment for and demand for medical equipment and services, implementation of and performance under the joint venture agreement by all parties, and other risks contained in reports filed by the company with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the company, are expressly qualified by the cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.Contact Us:In the US:The Piacente Group, Inc.Investor RelationsBrandi Floberg or Lee RothTel: (212) 481-2050Email: dehaier@tpg-ir.com In China:The Piacente Group, Inc.Investor RelationsWendy SunTel: +86-10-6590-7991Email: dehaier@tpg-ir.com Dehaier Medical Systems LimitedRita LiuCFOTel: +86-10-8844-5026Email: liuz@dehaier.com.cn
'/>"/>

SOURCE Dehaier Medical Systems Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dehaier Medical Announces First Quarter 2011 Financial Results
2. Dehaier Medical to Report First Quarter 2011 Financial Results on May 4
3. Dehaier Medical Chairman and CEO Issues Letter to Shareholders
4. Dehaier Medical Systems Signs New Distribution Agreement to Distribute eVent Medical Ventilators
5. Dehaier Medical Announces Fourth Quarter and Full-Year 2010 Financial Results
6. Dehaier Medical to Report Fourth Quarter and Full-Year 2010 Financial Results on March 7
7. Dehaier Medical Announces March Investor Presentations
8. Dehaier Medical Retains The Piacente Group as Strategic Investor Relations Consulting Firm
9. Dehaier Medical Announces Participation in Arab Health 2011
10. Dehaier Medical Announces Third Quarter 2010 Financial Results
11. Dehaier Medical Announces Conference Call to Discuss Third Quarter 2010 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)...   Pulmatrix, Inc ., (NASDAQ: PULM ... announced today that it was added to the Russell ... comprehensive set of U.S. and global equity indexes on ... milestone for Pulmatrix," said Chief Executive Officer Robert ... progress in developing drugs for crucial unmet medical needs, ...
(Date:6/23/2016)... Research and Markets has announced the addition of ... report to their offering. ... kidney failure, it replaces the function of kidneys by removing ... thus the treatment helps to keep the patient body,s electrolytes ... Increasing number of ESRD patients & substantial healthcare expenditure ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: ... 510(k) clearance for its Elecsys BRAHMS PCT (procalcitonin) assay ... sepsis or septic shock. With this clearance, Roche is ... a fully integrated solution for sepsis risk assessment and ... with bacterial infection and PCT levels in blood can ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... ... PawPaws brand pet supplements owned by Whole Health Supply is ... of felines. The formula is all-natural and is made from Chinese herbs that have ... Kidney Support Supplement Soft Chews are Astragalus Root Extract and Rehmannia Root Extract ...
(Date:6/25/2016)... , ... June 25, 2016 , ... ... policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at ... on several important health care topics including advance care planning, healthcare costs and ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... "With 30 ... their specific project," said Christina Austin - CEO of Pixel Film Studios. , ... and all within Final Cut Pro X . Simply select a ProHand generator ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. ... from injury. Recently, he has implemented orthobiologic procedures as a method for treating ... one of the first doctors to perform the treatment. Orthobiologics are substances that ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... A recent ... that most people are unfamiliar with. The article goes on to state that individuals ... also many of these less common operations such as calf and cheek reduction. The ...
Breaking Medicine News(10 mins):